Paediatric systemic lupus erythematosus as a manifestation of constitutional mismatch repair deficiency.

Published on Jul 1, 2020in Journal of Medical Genetics4.943
· DOI :10.1136/JMEDGENET-2019-106303
Helen Toledano15
Estimated H-index: 15
,
Naama Orenstein10
Estimated H-index: 10
(TAU: Tel Aviv University)
+ 12 AuthorsYael Goldberg17
Estimated H-index: 17
(Rabin Medical Center)
Sources
Abstract
Biallelic mutations in any of the four mismatch repair genes MSH2, MSH6, MLH1 and PMS2 result in one of the most aggressive childhood cancer predisposition syndromes, termed constitutional mismatch repair deficiency (CMMRD) syndrome. In addition to a very high tumour risk, the CMMRD phenotype is often characterised by the presence of signs reminiscent of neurofibromatosis type 1. Although paediatric systemic lupus erythematosus (pSLE) has been reported so far in three patients with CMMRD, it has not been considered a diagnostic feature of the syndrome. We report here two additional female patients with pSLE and CMMRD due to biallelic pathogenic variants in MSH6. Hence, there are a total of five out of approximately 200 (2.5%) currently reported patients with CMMRD that also have pSLE, suggesting pSLE should raise the suspicion of a diagnosis of CMMRD, especially if supported by additional indicative features
📖 Papers frequently viewed together
54 Citations
141 Citations
18 Citations
References21
Newest
#1Manon Suerink (LEI: Leiden University)H-Index: 4
#2Tim Ripperger (MHH: Hannover Medical School)H-Index: 16
Last. Katharina WimmerH-Index: 30
view all 17 authors...
Constitutional mismatch repair deficiency (CMMRD) is a rare childhood cancer predisposition syndrome caused by biallelic germline mutations in one of four mismatch-repair genes. Besides very high tumour risks, CMMRD phenotypes are often characterised by the presence of signs reminiscent of neurofibromatosis type 1 (NF1). Because NF1 signs may be present prior to tumour onset, CMMRD is a legitimate differential diagnosis in an otherwise healthy child suspected to have NF1/Legius syndrome without ...
24 CitationsSource
#1Arabella Young (UCSF: University of California, San Francisco)H-Index: 20
#2Zoe Quandt (UCSF: University of California, San Francisco)H-Index: 7
Last. Jeffrey A. Bluestone (UCSF: University of California, San Francisco)H-Index: 157
view all 3 authors...
The explosion in novel cancer immunotherapies has resulted in extraordinary clinical successes in the treatment of multiple cancers. Checkpoint inhibitors (CPIs) that target negative regulatory molecules have become standard of care. However, with the growing use of CPIs, alone or in combination with chemotherapy, targeted therapies, or other immune modulators, a significant increase in immune-related adverse events (irAEs) has emerged. The wide-ranging and currently unpredictable spectrum of CP...
60 CitationsSource
#1Shelly I. ShiranH-Index: 8
#2Liat Ben-SiraH-Index: 22
Last. Rina DvirH-Index: 16
view all 8 authors...
BACKGROUND AND PURPOSE: Biallelic constitutional mutations in DNA mismatch repair genes cause a distinct syndrome, constitutional mismatch repair deficiency syndrome (CMMRD), characterized by cancers from multiple organs, most commonly brain tumors, during childhood. Surveillance protocols include total and brain MR imaging among other modalities to enable early detection of tumors. Brain surveillance scans revealed prominent brain developmental venous anomalies (DVAs) in some patients. DVAs are...
12 CitationsSource
#1Victoria Katharina Tesch (University of Graz)H-Index: 2
#2Hanna IJspeert (EUR: Erasmus University Rotterdam)H-Index: 17
Last. Markus G. Seidel (University of Graz)H-Index: 31
view all 24 authors...
Immunoglobulin class-switch recombination (CSR) and somatic hypermutations (SHM) are prerequisites for antibody and immunoglobulin receptor maturation and adaptive immune diversity. The mismatch repair (MMR) machinery, consisting of homologues of MutS, MutL, and MutS (MSH2/MSH6, MLH1/PMS2, and MSH2/MSH3, respectively) and other proteins, is involved in CSR, primarily acting as a backup for nonhomologous end-joining repair of activation-induced cytidine deaminase-induced DNA mismatches and, fu...
11 CitationsSource
#1Erika Leenders (Radboud University Nijmegen)H-Index: 2
#2Harm Westdorp (Radboud University Nijmegen)H-Index: 11
Last. Marjolijn C.J. Jongmans (Radboud University Nijmegen)H-Index: 24
view all 8 authors...
Constitutional MisMatch Repair Deficiency (CMMRD) is caused by homozygous or compound heterozygous germline variants in one of the mismatch repair (MMR) genes (MSH2, MSH6, PMS2, MLH1). This syndrome results in early onset colorectal cancer, leukemia and lymphoma, brain tumors and other malignancies. Children with CMMRD are at high risk of developing multiple cancers and cancer surveillance does not guarantee detection of cancer at a curable stage. The development of a preventive treatment strate...
18 CitationsSource
#1Kevin A. Strauss (Clinic for Special Children)H-Index: 39
#2Claudia Gonzaga-Jauregui (Regeneron)H-Index: 30
Last. Erik G. Puffenberger (Clinic for Special Children)H-Index: 40
view all 20 authors...
We integrated whole-exome sequencing (WES) and chromosomal microarray analysis (CMA) into a clinical workflow to serve an endogamous, uninsured, agrarian community. Seventy-nine probands (newborn to 49.8 years) who presented between 1998 and 2015 remained undiagnosed after biochemical and molecular investigations. We generated WES data for probands and family members and vetted variants through rephenotyping, segregation analyses, and population studies. The most common presentation was neurolog...
29 CitationsSource
#1Manon Suerink (LEI: Leiden University)H-Index: 4
#2Thomas P. Potjer (LEI: Leiden University)H-Index: 10
Last. Maartje Nielsen (LEI: Leiden University)H-Index: 28
view all 7 authors...
Constitutional mismatch repair deficiency (CMMRD) is a rare, recessively inherited childhood cancer predisposition syndrome caused by biallelic germline mutations in one of the mismatch repair genes. The CMMRD phenotype overlaps with that of neurofibromatosis type 1 (NF1), since many patients have multiple cafe-au-lait macules (CALM) and other NF1 signs, but no germline NF1 mutations. We report of a case of a healthy 6-year-old girl who fulfilled the diagnostic criteria of NF1 with >6 CALM and f...
18 CitationsSource
#1Laura C. Cappelli (Johns Hopkins University)H-Index: 17
#2Anna Kristina Gutierrez (Johns Hopkins University)H-Index: 5
Last. Ami A. Shah (Johns Hopkins University)H-Index: 16
view all 4 authors...
Objective Immune checkpoint inhibitors (ICIs) are improving prognoses in advanced stage cancers, but they also lead to immune-related adverse events (IRAEs). IRAEs targeting many organ systems have been reported, but musculoskeletal and rheumatic IRAEs have not been well-characterized. We systematically reviewed published literature on musculoskeletal and rheumatic IRAEs to better understand prevalence and clinical characteristics. Methods Medline and CENTRAL databases were searched for articles...
177 CitationsSource
#1Sasha Bernatsky (MUHC: McGill University Health Centre)H-Index: 63
#2Ann E. Clarke (U of C: University of Calgary)H-Index: 75
Last. Rosalind Ramsey-GoldmanH-Index: 85
view all 20 authors...
Objective To determine cancer incidence in a large pediatric-onset systemic lupus erythematosus (SLE) population. Methods Data were examined from 12 pediatric SLE registries in North America. Patients were linked to their regional cancer registries to detect cancers observed after cohort entry, defined as date first seen in the clinic. The expected number of malignancies was obtained by multiplying the person-years in the cohort (defined from cohort entry to end of followup) by the geographicall...
6 CitationsSource
#1Uri Tabori (U of T: University of Toronto)H-Index: 66
#2Jordan R. Hansford (Royal Children's Hospital)H-Index: 18
Last. Laurence BrugièresH-Index: 72
view all 7 authors...
Replication proofreading is crucial to avoid mutation accumulation in dividing cells. In humans, proofreading and replication repair is maintained by the exonuclease domains of DNA polymerases and the mismatch repair system. Individuals harboring germline mutations in genes involved in this process are at increased risk of early cancers from multiple organs. Biallelic mutations in any of the four mismatch repair genes MSH2, MSH6, MLH1, and PMS2 result in one of the most aggressive childhood canc...
89 CitationsSource
Cited By3
Newest
Biallelic germline mismatch repair (MMR) gene (MLH1, MSH2, MSH6, and PMS2) mutations are an extremely rare event that causes constitutional mismatch repair deficiency (CMMRD) syndrome. CMMRD is underdiagnosed and often debuts with pediatric malignant brain tumors. A high degree of clinical awareness of the CMMRD phenotype is needed to identify new cases. Immunohistochemical (IHC) assessment of MMR protein expression and analysis of microsatellite instability (MSI) are the first tools with which ...
Source
#1Melyssa AronsonH-Index: 31
#2Chrystelle Colas (University of Paris)H-Index: 25
Last. Uri Tabori (U of T: University of Toronto)H-Index: 66
view all 14 authors...
Background Constitutional mismatch repair deficiency syndrome (CMMRD) is the most aggressive cancer predisposition syndrome associated with multiorgan cancers, often presenting in childhood. There is variability in age and presentation of cancers and benign manifestations mimicking neurofibromatosis type 1. Genetic testing may not be informative and is complicated by pseudogenes associated with the most commonly associated gene, PMS2. To date, no diagnostic criteria exist. Since surveillance and...
4 CitationsSource
#1Manon Suerink (LEI: Leiden University)H-Index: 4
#2Katharina Wimmer (Innsbruck Medical University)
Last. Hans F. A. Vasen (LEI: Leiden University)H-Index: 116
view all 17 authors...
6 CitationsSource